Focal adhesion kinase inhibitors, a heavy punch to cancer
Abstract Kinases are the ideal druggable targets for diseases and especially were highlighted on cancer therapy. Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase and its aberrant signaling extensively implicates in the progression of most cancer types, involving in cancer cell growth, a...
Enregistré dans:
Auteurs principaux: | , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Springer
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f8375424d64f46afbf8002a1c77b3cca |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|